causal
Compounding Learning Creates Hard-to-Replicate Lead
Early leaders in a therapy modality accumulate compounding advantages as each successful drug adds data and know-how, making it hard for competitors to catch up, as Genentech and Biogen did with protein drugs.
causalpending
Speaker
Jason KellyEvidence Quote
“Why did Genentech gets so big? Why did Biogen gets so big? Because they were right there on the first day.”
Created: 11/15/2026, 7:57:10 PM
Your notes
Loading notes...